Targeting notch pathway enhances rapamycin antitumor activity in pancreas cancers through PTEN phosphorylation

BACKGROUND: Pancreas cancer is one of most aggressive human cancers with the survival rate for patients with metastatic pancreas cancer at 5-6 months. The poor survival demonstrates a clear need for better target identification, drug development and new therapeutic strategies. Recent discoveries hav...

Descripción completa

Detalles Bibliográficos
Autores principales: Vo, Kevin, Amarasinghe, Barushi, Washington, Kay, Gonzalez, Adriana, Berlin, Jordan, Dang, Thao P
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3253061/
https://www.ncbi.nlm.nih.gov/pubmed/22074495
http://dx.doi.org/10.1186/1476-4598-10-138

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3253061/
https://www.ncbi.nlm.nih.gov/pubmed/22074495
http://dx.doi.org/10.1186/1476-4598-10-138

Ejemplares similares